FY2025 · period end Dec '25 · from the 10-K filed May 15, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | negative: -$0.00B | negative: -$0.00B | $0.00B | — | — |
| Operating Income | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Net Income | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.01B | negative: -$0.00B |
| EPS (Diluted) | negative: -$0.08 | negative: -$0.11 | negative: -$0.08 | negative: -$0.26 | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Total Liabilities | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stockholders' Equity | negative: -$0.01B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | $0.01B |
| Cash & Equivalents | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | negative: -30.3% | negative: -1952.2% | 60.5% | — | — |
| Operating Margin | negative: -1.7% | negative: -0.7% | negative: -0.6% | negative: -0.9% | negative: -0.2% |
| Net Margin | negative: -1.4% | negative: -0.7% | negative: -0.5% | negative: -2.4% | negative: -0.3% |
| Return on Equity | 31.1% | 64.6% | 109.4% | 1366.2% | negative: -18.2% |
| Return on Assets | negative: -53.7% | negative: -59.9% | negative: -42.3% | negative: -76.2% | negative: -11.9% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001493152-26-024181 | May 18, 2026 | May 18, 2026 | May 18, 2026 20:15 UTC | EDGAR |
| 10-K | 0001493152-26-023606 | Dec 31, 2025 | May 15, 2026 | May 15, 2026 18:45 UTC | EDGAR |
| 8-K | 0001493152-26-016949 | Apr 15, 2026 | Apr 16, 2026 | Apr 16, 2026 10:02 UTC | EDGAR |
| 8-K | 0001493152-26-003883 | Jan 26, 2026 | Jan 28, 2026 | Jan 28, 2026 13:00 UTC | EDGAR |
| 10-Q | 0001493152-25-024182 | Sep 30, 2025 | Nov 19, 2025 | Nov 19, 2025 15:36 UTC | EDGAR |
| 10-Q | 0001641172-25-024970 | Jun 30, 2025 | Aug 20, 2025 | Aug 20, 2025 19:04 UTC | EDGAR |
| 10-Q | 0001641172-25-016872 | Mar 31, 2025 | Jun 27, 2025 | Jun 27, 2025 20:00 UTC | EDGAR |
| 10-K | 0001641172-25-008967 | Dec 31, 2024 | May 7, 2025 | May 7, 2025 13:00 UTC | EDGAR |
Direct links to SEC EDGAR. AIXN has additional filings available on the SEC site.
6 numbers AiXin Life International, Inc. later changed — same XBRL tag, both filings linked.
Liabilities·As of Dec 31, 2020
Major restatementwas$1.2M
Revised up in a 8-K/A.
Net Income (Loss) Attributable to Parent·FY 2021
Major restatementwas-$267.2K
Revised down in a 8-K/A.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q3 2021
Major restatementwas-$72K
Revised down in a 8-K/A.
Operating Income (Loss)·Q3 2021
Major restatementwas-$93.5K
Revised down in a 8-K/A.
Net Income (Loss) Attributable to Parent·Q3 2021
Major restatementwas-$146.1K
Revised down in a 8-K/A.
Revenues·FY 2020
Major restatementwas$2.5M
Revised up in a 8-K/A. Any P/S built on the original was 48.8% too high.
AIXN is not the only one.
See every restatement we've found across the market — or get an alert the next time AIXN revises a number.
Restatements are detected by comparing every vintage of a fact across all of AiXin Life International, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows AIXN's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling AiXin Life International, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on AIXN yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on AIXN and publish the result to your public profile.
Ask about AiXin Life International, Inc.
Continue in Workspace — cited answers on AIXN, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs